Minnesota records an A and a B on latest state telemedicine report cards.
Industry
The Mayo Clinic was the state’s top earning health institution, taking in nearly $10.8 million from medical device makers and others in the field.
Five life sciences research projects nearing market stage land MN-REACH funding.
Patent application filed on antibody used for individualized cancer treatments.
Latest Articles
Patent application filed on antibody used for individualized cancer treatments.
Blue Cross surveys understanding of health plans.
Nevertheless, value of the retailer’s stock dropped 10 percent after its quarterly profits did match up to analyst expectations.
The offer is said to be worth $590 million. If approved, Delta would have the option to ultimately own 49 percent of Aeroméxico.
A rapid expansion phase and lack of customer interest is said to have pushed the outdoors retailer into financial trouble.
The Shoreview-based check printing and marketing company plans to buy all RDM common stock at a 14 percent premium.
Subsidies are notoriously difficult to track, but here’s what we know.
The medtech company’s sales rose 11 percent year-over-year during the three-month period.
Latest coffee fad is designed to expand coffee audience.
The unit could sell for as much as $5 billion, according to people familiar with the matter.
The Brothers Snyder laud hometown’s buzzing bio-business startup scene.
Medtech firm went public in 2015.
Minnesotans pay $32 less than the national average for single coverage.
Howard Root, CEO of the medtech company, said the accusations have “no merit and we’ll prove it.”
It would allow therapies to bypass ‘blood-brain barrier’ to treat neuro conditions.
MSP Communications, 953 Westgate Drive, Suite 107, St. Paul, MN, 55114 © 2026 Key Enterprises LLC All rights reserved.